Positive and negative regulation of EAAT2 by NF-κB:: a role for N-myc in TNFα-controlled repression

被引:192
作者
Sitcheran, R
Gupta, P
Fisher, PB
Baldwin, AS
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Columbia Univ Coll Phys & Surg, Med Ctr, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Med Ctr, Dept Neurosurg, New York, NY 10032 USA
[4] Columbia Univ Coll Phys & Surg, Med Ctr, Dept Urol, New York, NY 10032 USA
[5] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
关键词
EAAT2; EGF; N-myc; NF-kappa B; TNF alpha;
D O I
10.1038/sj.emboj.7600555
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The glutamate transporter gene, EAAT2/GLT-1, is induced by epidermal growth factor (EGF) and downregulated by tumor necrosis factor alpha (TNFalpha). While TNFalpha is generally recognized as a positive regulator of NF-kappaB-dependent gene expression, its ability to control transcriptional repression is not well characterized. Additionally, the regulation of NF-kappaB by EGF is poorly understood. Herein, we demonstrate that both TNFalpha-mediated repression and EGF-mediated activation of EAAT2 expression require NF-kappaB. We show that EGF activates NF-kappaB independently of signaling to IkappaB. Furthermore, TNFalpha can abrogate IKKbeta- and p65- mediated activation of EAAT2. Our results suggest that NF-kappaB can intrinsically activate EAAT2 and that TNFa mediates repression through a distinct pathway also requiring NF-kappaB. Consistently, we find that N-myc is recruited to the EAAT2 promoter with TNFalpha and that N-myc-binding sites are required for TNFalpha-mediated repression. Moreover, N-myc overexpression inhibits both basal and p65- induced activation of EAAT2. Our data highlight the remarkable specificity of NF-kappaB activity to regulate gene expression in response to diverse cellular signals and have implications for glutamate homeostasis and neurodegenerative disease.
引用
收藏
页码:510 / 520
页数:11
相关论文
共 49 条
[1]   IDENTIFICATION OF 2 NOVEL REGULATORY ELEMENTS WITHIN THE 5'-UNTRANSLATED REGION OF THE HUMAN (A)GAMMA-GLOBIN GENE [J].
AMROLIA, PJ ;
CUNNINGHAM, JM ;
NEY, P ;
NIENHUIS, AW ;
JANE, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12892-12898
[2]   IκB kinase α and p65/Re1A contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IκBα degradation [J].
Anest, V ;
Cogswell, PC ;
Baldwin, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :31183-31189
[3]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[4]   Inhibition of oxidant-induced nuclear Factor-κB activation and inhibitory-κBα degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor:: Key role of phospholipase-γ isoform [J].
Banan, A ;
Zhang, LJ ;
Shaikh, M ;
Fields, JZ ;
Farhadi, A ;
Keshavarzian, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :356-368
[5]   PKC-β1 isoform activation is required for EGF-induced NF-κB inactivation and IκBα stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers [J].
Banan, A ;
Zhang, LJ ;
Farhadi, A ;
Fields, JZ ;
Shaikh, M ;
Keshavarzian, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 286 (03) :C723-C738
[6]   A conserved signaling pathway: The Drosophila Toll-Dorsal pathway [J].
Belvin, MP ;
Anderson, KV .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1996, 12 :393-416
[7]   Epidermal growth factor-induced nuclear factor κB activation:: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells [J].
Biswas, DK ;
Cruz, AP ;
Gansberger, E ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8542-8547
[8]   Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB [J].
Campbell, KJ ;
Rocha, S ;
Perkins, ND .
MOLECULAR CELL, 2004, 13 (06) :853-865
[9]   NIK is a component of the EGF/heregulin receptor signaling complexes [J].
Chen, DY ;
Xu, LG ;
Chen, L ;
Li, LX ;
Zhai, ZH ;
Shu, HB .
ONCOGENE, 2003, 22 (28) :4348-4355
[10]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634